title: Central nervous system findings on functional magnetic resonance imaging in patients before and after treatment with anticholinergic medication.
authors.affiliation: Department of Urology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140, USA. Pontarm@tuhs.temple.edu
authors.forename: Michel A
authors.initials: MA
authors.lastname: Pontari
authors.forename: Feroze B
authors.initials: FB
authors.lastname: Mohamed
authors.forename: Steve
authors.initials: S
authors.lastname: Lebovitch
authors.forename: Shweta
authors.initials: S
authors.lastname: Moonat
authors.forename: Brett
authors.initials: B
authors.lastname: Lebed
authors.forename: Michael R
authors.initials: MR
authors.lastname: Ruggieri
authors.forename: Scott H
authors.initials: SH
authors.lastname: Faro
mesh_terms: D001559:Benzhydryl Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D001921:Brain / Q000502:physiology*; D003408:Cresols / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D010665:Phenylpropanolamine / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011795:Surveys and Questionnaires; D000068737:Tolterodine Tartrate; D016896:Treatment Outcome; D053201:Urinary Bladder, Overactive / Q000188:drug therapy* / Q000503:physiopathology*
chemical_list: D001559:Benzhydryl Compounds; D003408:Cresols; D018727:Muscarinic Antagonists; D010919:Placebos; D010665:Phenylpropanolamine; D000068737:Tolterodine Tartrate